关于奎尔丁最佳提取和低血糖效应的研究
Lei Zhang1, Ming-Yue Pan1, Tao Li1
1College of Life Science and Technology, Mudanjiang Normal University, Mudanjiang 157011, China.
Evidence-based complementary and alternative medicine : eCAM
|September 7, 2023
概括
普尔斯兰中的奎尔塞丁有效降低了血糖,并通过抑制二二酶IV (DPP-IV) 在2型糖尿病小鼠中改善了胰岛素敏感性. 这种天然化合物在糖尿病管理方面表现有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
- 代谢疾病 代谢疾病
背景情况:
- 2型糖尿病是一个日益严重的全球健康问题.
- 双基酶IV (DPP-IV) 是2型糖尿病管理的关键标.
- 天然化合物正在探索它们在糖尿病中的治疗潜力.
研究的目的:
- 为了从Portulaca oleracea L.中提取奎尔丁.
- 在2型糖尿病小鼠模型中评估奎尔塞丁的低血糖效应.
- 为了研究奎尔塞丁对DPP-IV活性的抑制作用.
主要方法:
- 使用响应表面方法 (RSM) 来从Portulaca oleracea L.中优化切丁提取.
- 建立了一种2型糖尿病小鼠模型,用于口服奎尔丁的使用.
- 评估禁食血糖,血清DPP-IV活性,体重,胰岛素水平,并进行口服葡萄糖耐受性测试.
主要成果:
- 优化的提取产生了0.675%的奎尔塞丁.
- 奎尔丁治疗显著降低了空腹血糖和血清DPP-IV活性.
- 奎尔赛丁增加了体重和胰岛素水平,并且剂量取决于改善了葡萄糖耐受性.
结论:
- 从Portulaca oleracea L.中提取的奎尔塞显示出显著的低血糖效应.
- 奎尔提改善了2型糖尿病小鼠的胰岛素敏感性,可能是通过DPP-IV抑制.
- 这项研究支持奎尔素作为2型糖尿病的潜在治疗剂.
相关概念视频
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
203
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
203
01:26Glucose Absorption Into the Small Intestine
31.8K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.8K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230